Neuronetics, Inc.

NeuroStar Advances Practice Innovation with First-Ever TMS Integration with an EHR/EMR System

Neuronetics (NASDAQ: STIM) announced the integration of its TrakStar practice management platform with AdvancedMD, a cloud EHR used by more than 65,000 practitioners across 13,000 independent practices, making NeuroStar the first TMS system to integrate with an EHR/EMR. The integration will be available to NeuroStar providers already using AdvancedMD starting in Q4, routing treatment data into the same system practices use for scheduling, clinical records, and revenue cycle, and cutting duplicate documentation across a multi-session TMS course of care. NeuroStar has treated more than 253,000 patients with over 9.1 million sessions nationwide; the tie-up gives AdvancedMD practices a lower-friction path to adding a TMS service line while giving NeuroStar a new adoption lever in practice platform decisions.

•1mo ago

Neuronetics Reports Second Quarter 2026 Financial and Operating Results

Neuronetics reported Q2 revenue of $41.6 million, up 9.1% year-over-year, driven primarily by a 16.8% increase in Greenbrook clinic revenue to $26.9 million. The company achieved a significant operational milestone, flipping Adjusted EBITDA to positive $0.3 million compared to a loss of $5.6 million in the prior year, while the net loss narrowed to $3.4 million. Neuronetics reaffirmed its full-year 2026 revenue guidance of $160 million to $164 million and tightened its operating expense outlook to a range of $95 million to $100 million. Leadership changes included the appointment of Nir Naor as CFO and the promotion of Cory Anderson to lead the Greenbrook business unit.

•2mo ago

Neuronetics and Jorey Chernett Announce Shared Vision

Neuronetics and its second-largest shareholder, Jorey Chernett, established a framework for alignment, with Chernett affirming confidence in the company's balance sheet and management execution. Chernett will gain the opportunity to recommend a new board member, augmenting direct shareholder representation in governance. Largest shareholder Madryn Asset Management reaffirmed its conviction in the long-term value of the business, backing the company's strategic direction.

•2mo ago

Greenbrook Opens National Center of Excellence for Advanced Interventional Psychiatry in Rockville, Maryland

Neuronetics announced the grand opening of Greenbrook Mental Wellness Centers’ National Center of Excellence in Rockville, Maryland. The nearly 7,000-square-foot facility is the largest Greenbrook location to date and is designed to support high-volume NeuroStar TMS and SPRAVATO operations. This flagship center will serve as a national blueprint for interventional psychiatry and act as a pilot site for emerging treatment modalities.

•3mo ago

Neuronetics Appoints Robert Greene as Senior Vice President Sales

Neuronetics appointed Robert Greene as Senior Vice President of Sales, effective June 1, 2026. Greene brings extensive experience leading commercial strategy and sales organizations in healthcare and medical technology. The Compensation Committee authorized an inducement grant of 200,000 restricted stock units, vesting in four equal annual installments.

•4mo ago

Neuronetics Reports First Quarter 2026 Financial and Operating Results

Neuronetics reported Q1 2026 revenue of $34.5 million, an 8% increase from the prior year, while narrowing its net loss per share to $(0.16) from $(0.21). Operational efficiency improved significantly, with net cash used in operations decreasing by $7.6 million to $9.4 million despite a one-time $5.0 million debt principal payment made during the quarter. The company maintained its full-year 2026 revenue guidance of $160 million to $166 million and announced an expansion of Optum/UHC/UBH's TMS clinical policy to allow nurse practitioners to administer NeuroStar therapy.

•5mo ago